Exicure (NASDAQ:XCUR) Announces Earnings Results

Exicure (NASDAQ:XCUR) released its quarterly earnings results on Tuesday. The company reported ($3.39) earnings per share for the quarter, Zacks reports.

Exicure Stock Down 4.5 %

NASDAQ XCUR opened at $12.40 on Wednesday. The business has a 50 day moving average price of $10.34 and a two-hundred day moving average price of $9.39. Exicure has a fifty-two week low of $1.44 and a fifty-two week high of $36.00. The stock has a market cap of $32.31 million, a PE ratio of -5.99 and a beta of 3.84.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.